Pancreatic Cancer Research

ResearcherInstitute of Oncology LjubljanaNo recent work listed

Bostjan Markelc

Provisional: name at one institution (moderate confidence, 0.60), identity_conf@1As of 8 November 2026

Known by name at one institution; no external author ID yet. Sources: ClinicalTrials.gov.

Their work

Papers
0
Trials
1
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2020: 1 trial

Trials 1

  1. Electrochemotherapy of Posterior Resection Surface for Lowering Disease Recurrence Rate in Pancreatic Cancer (PanECT Study) Study chair NCT04281290↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maša Bošnjak · 1 shared trial, 2020 · strength 0.17
  2. Blaž Trotovšek · 1 shared trial, 2020 · strength 0.17
  3. Miha Petrič · 1 shared trial, 2020 · strength 0.17
  4. Maja Čemažar · 1 shared trial, 2020 · strength 0.17
  5. Mihajlo Djokić · 1 shared trial, 2020 · strength 0.17
  6. Gregor Serša · 1 shared trial, 2020 · strength 0.17
  7. Žan Čebron · 1 shared trial, 2020 · strength 0.17
  8. David Badovinac · 1 shared trial, 2020 · strength 0.17

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.